Biopsy effects on children born after genetic testing
This study compares children born after preimplantation genetic testing with a small biopsy of the embryo to those born without such testing. It aims to see if the biopsy affects a child's health and development during their first year of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be at least 1 year old at the time of the study.
- Your child should not have any major health problems affecting growth.
- You must be willing to give informed consent for the study.
- You were between 18 and 43 years old when you became pregnant.
- You gave birth to a single baby (not twins or more) from a single pregnancy sac.
- You had a frozen embryo transfer (FET) and, for cases, also had preimplantation genetic testing (PGT).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an artificial intelligence (AI) tool that tries to predict whether embryos are healthy (have the right number of chromosomes) without having to take a sample from them. If it works, it could make embryo testing less invasive and help you choose the best embryo for transfer.
This trial is for women aged 35–40 doing IVF. It compares genetic testing of embryos before transfer to standard care, to see if it improves pregnancy success.
This study tests an upgraded genetic test (PGT-A) that checks embryos for extra or missing chromosomes before transfer, which may improve the chance of a successful pregnancy. It is for people doing IVF who face challenges like older age, repeated failures, or miscarriages.
This trial follows up with people who chose to participate in research when getting preimplantation genetic testing (testing genes in embryos). It may help researchers understand outcomes and improve future genetic testing and counseling.
This study examines genetic material from miscarriages to understand why early pregnancy loss happens. Researchers analyze a blood sample taken right after miscarriage to look for clues that might help explain what went wrong and potentially prevent future losses.
This study looks at how well a genetic test on embryos (called PGT-M) can find specific single-gene disorders. It will help doctors learn more about these tests and improve care for families.
Hear when a new Preimplantation Genetic Testing (PGT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.